MMP9 and Alport syndrome: We showed that increased susceptibility of defective human Alport GBM to proteolytic degradation is mediated by three different matrix metalloproteinases (MMPs)—MMP-2, MMP-3, and MMP-9—which influence the progression of renal dysfunction inα3(IV)−/− mice, a model for human Alport syndrome.